[1]
A S, V. et al. 2024. Enhancing cancer care with improved checkpoint inhibitors: a focus on PD-1/PD-L1. EXCLI Journal. 23, (Oct. 2024), 1303–1326. DOI:https://doi.org/10.17179/excli2024-7783.